πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 33 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12269856

Hepcidin analogues and uses thereof

Protagonist Therapeutics, Inc. Β· Granted Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12234300

Conjugated hepcidin mimetics

Protagonist Therapeutics, Inc. Β· Granted Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12072338

Pharmaceutical peptides for the treatment of inflammatory diseases

PROTAGONISTS LTD. Β· Granted Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12018057

Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

Protagonist Therapeutics, Inc. Β· Granted Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11939361

Compositions of peptide inhibitors of Interleukin-23 receptor

Protagonist Therapeutics, Inc. Β· Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11884748

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bow

Protagonist Therapeutics, Inc. Β· Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11845808

Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

Protagonist Therapeutics, Inc. Β· Granted Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11840581

Ξ±4Ξ²7 thioether peptide dimer antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11807674

Hepcidin analogues and uses thereof

Protagonist Therapeutics, Inc. Β· Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11753443

Conjugated hepcidin mimetics

Protagonist Therapeutics, Inc. Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11472842

Analogues of hepcidin mimetics with improved in vivo half lives

Protagonist Therapeutics, Inc. Β· Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11111272

Ξ±4Ξ±7 peptide monomer and dimer antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11041000

Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

Protagonist Therapeutics, Inc. Β· Granted Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10941183

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bow

Protagonist Therapeutics, Inc. Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10787490

Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

Protagonist Therapeutics, Inc. Β· Granted Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10729676

Opioid agonist peptides and uses thereof

Protagonist Therapeutics, Inc. Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626146

Ξ±4Ξ²7 thioether peptide dimer antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10501515

Hepcidin analogues and uses thereof

Protagonist Therapeutics, Inc. Β· Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10442846

Hepcidin analogues and uses thereof

Protagonist Therapeutics, Inc. Β· Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10407468

Methods for synthesizing Ξ±4Ξ²7 peptide antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10301371

Cyclic monomer and dimer peptides having integrin antagonist activity

Protagonist Therapeutics, Inc. Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10278957

Opioid agonist peptides and uses thereof

Protagonist Therapeutics, Inc. Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10196424

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bow

Protagonist Therapeutics, Inc. Β· Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10059744

Ξ±4Ξ²7 thioether peptide dimer antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted